Business Insurance:  Roughly four in 10 lost-time workers compensation claims involved at least one injectable drug or procedure within 24 months of injury, and costs for self-administered drugs, such as those use for weight loss, doubled in six years, according to a new study by the Workers Compensation Research Institute.

The report examines injectable therapies across 28 states, including both clinician-administered procedures — such as epidural steroid injections, nerve blocks and joint injections — and self-administered injectable medications. Waltham, Massachusetts-based WCRI found that injectable therapies represent a significant and growing share of medical spending in workers compensation claims.

You can read their full report here. The newly-released WCRI study is Injectable Therapies in Workers’ Compensation.  You can find more information, including details on how to download a copy, elsewhere on our website; we also have a video about the study!